Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 15,224

Document Document Title
WO/2019/212211A1
A novel chromane derivative, (3'-hydroxy-4'-ethoxybenzyl)-5,6,7-trimethoxy-2H-1-benzopyra n (SH-17059 (1)) is disclosed herein. This chromane derivative has been found to inhibit blood vessel cell growth and proliferation, providing a pr...  
WO/2019/210422A1
The present disclosure relates to Vitamin E derivatives as multi-scale imaging agents. In particular, the present disclosure relates to isotopically labeled Vitamin E derivatives, and their use as multi-scale imaging agents.  
WO/2019/185938A3
The present invention is directed towards the use of substituted chroman-6- ols with extended lipophilic side chains of formula (I) wherein one of the two substituents R1 and R2 is C12-21-alkyl and the other of the two substituents R1 an...  
WO/2019/212997A1
The present disclosure relates to compositions and methods for the biosynthetic preparation of urolithin compounds, pharmaceutical compositions and kits containing them, and methods of using them.  
WO/2019/213553A1
Disclosed herein are polymeric dyes, their preparation, and their uses. Some embodiments relate to their use for detecting biological activity in samples, such as the presence of bacteria in blood.  
WO/2019/205909A1
An eutectic crystal of temozolomide and baicalein and a preparation method therefor. Specifically, the X-ray powder diffraction pattern of the eutectic crystal has characteristic peaks at 2theta values of 7.7 ± 0.2°, 8.6 ± 0.2°, and ...  
WO/2019/210103A2
Provided herein are inhibitors of SLC26A3, which is an anion (CV, HCO3, oxalate) exchanger expressed in intestinal epithelial cells. SLC26A3 inhibitors have potential utility for treatment of constipation including chronic idiopathic con...  
WO/2019/208043A1
[Problem] To provide a method for simply producing various N-unprotected imine compounds inexpensively and safely. [Solution] This method for producing a N-unprotected imine compound comprises reacting a ketone compound and a nitrogen so...  
WO/2019/203491A1
The present specification provides a compound of formula 1 and an organic light emitting device comprising same.  
WO/2019/199068A1
The present specification relates to a compound represented by chemical formula 1 and an organic light emitting diode comprising same.  
WO/2019/198018A1
The invention relates to a personal care product for alleviating skin dryness, including facial skin dryness, body dryness, and breast skin dryness and for use as a massage oil. Embodiments of the personal care product include a formulat...  
WO/2019/199776A1
Described herein are methods of treating neuron inflammation conditions, for example, amyotropic lateral sclerosis and prion disease, comprising administering a therapeutically effective amount of a combination of cromolyn or a cromolyn ...  
WO/2019/198678A1
The present invention pertains to a lactone compound represented by general formula (A), and an ether compound represented by general formula (B). [In formula (A), R is a hydrogen atom or R1, R' is R1 if R is a hydrogen atom, carbon bond...  
WO/2019/191830A1
The present application relates generally to the treatment of integumentary wounds (including chronic and acute wounds involving both cutaneous and mucous membranes), and in particular to topical formulations and instillates comprising o...  
WO/2019/193068A1
The present invention relates to a process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group. The present invention also concerns the use of carbon labeled organic compounds containing a ca...  
WO/2019/194136A1
Provided are a photosensitive composition having an excellent sensitivity, a cured film, a method for manufacturing a color filter, a color filter, a solid-state imaging element, and an image display device. The photosensitive compositio...  
WO/2019/194384A1
The present specification provides a compound represented by chemical formula 1, and a photosensitive resin composition, a photosensitive material, a color filter and a display device which include same.  
WO/2019/184089A1
Disclosed are a compound represented by formula II, a preparation method therefor and an application thereof. Using the compound represented by formula II to synthesize lanreotide has the following advantages: 1. during a reaction, a car...  
WO/2019/185900A1
The present invention is directed to a process for the manufacture of a compound of formula (III), comprising the step of reacting a compound of formula (I) with a compound of formula (IIA), (IIB) or (IIC) in the presence of an acid cata...  
WO/2019/185938A2
The present invention is directed towards the use of substituted chroman-6- ols with extended lipophilic side chains of formula (I) wherein one of the two substituents R1 and R2 is C12-21-alkyl and the other of the two substituents R1 an...  
WO/2019/185898A1
The present invention is directed towards the use of 2H-chromens and their derivatives of formula (I) and/or of formula (II) wherein R1 and R2 are independently from each other H or C1-11-alkyl or (CH2)n— OH with n being an integer fro...  
WO/2019/185941A1
The present invention is directed towards the use of substituted chroman-6-ols with extended lipophilic side chains of formula (I) wherein one of the two substituents R1 and R2 is C12-21-alkyl and the other of the two substituents R1 and...  
WO/2019/185904A1
The present invention is directed to a process for the manufacture of a compound of formula (III), comprising the step of reacting a compound of formula (I) with a compound of formula (II) in the presence of an acid catalyst and in a mix...  
WO/2019/191189A1
The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disor...  
WO/2019/183589A1
The present disclosure relates generally to eukaryotic initiation factor 2B modulators of formula A, or a pharmaceutically acceptable salt, stereoisomer, or mixture of stereoisomers thereof and methods of making and using thereof.  
WO/2019/180505A1
Cannabis pods comprising a defined dose of cannabis and methods for making said pods. This method comprises milling or grinding the cannabis, passing it through a mesh or sieve, determining the desired amount of cannabinoid, and encapsul...  
WO/2019/181954A1
Provided are: a polymer for forming an insulating layer in which contact holes can be formed, the polymer dissolving in a lower aliphatic alcohol and photocrosslinking in a short period of time with ultraviolet rays; a polymer that can b...  
WO/2019/178689A1
A method for promoting weight management in a mammal is provided, comprising administering to the mammal a composition comprising at least one weight loss agent and at least one mitochondria enhancing agent. The weight loss agent may be ...  
WO/2019/173582A1
In alternative embodiments, provided are processes comprising the continuous isolation and purification of cannabinoids and further isomerization of the purified cannabidiol to Δ8tetrahydrocannabinol ( Δ8THC) and Δ9tetrahydrocannabino...  
WO/2019/172699A1
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.  
WO/2019/168198A1
[Problem] To provide a non-fluorescent rhodamine dye which forms a TICT state. [Solution] A compound represented by general formula (I) or a salt thereof.  
WO/2019/168972A1
Disclosed are methods for preparing a salt of urolithin A and, in turn, urolithin A. The methods are advantageous for the large-scale preparation of urolithin A or a pharmaceutically acceptable salt thereof.  
WO/2019/169001A1
The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.  
WO/2019/168199A1
[Problem] To provide a fluorescent probe which includes, as the base nucleus, a fluorescent skeleton functioning in the visible light region and which makes carboxypeptidase activity visible with high sensitivity. [Solution] A compound r...  
WO/2019/161509A1
An apparatus and method is provided for producing kief from cannabis plants. The apparatus includes a drum that rotates about a horizontal axis that cannabis plants are placed inside. As the drum rotates, kief separates from the cannabis...  
WO/2019/164914A1
The present inventions relates to compounds and compositions and their applications as pharmaceuticals for ameliorating injury to, or weakness of, or loss of, bone, or to prevent bone fractures. Exemplified herein is the administration t...  
WO/2019/164689A1
A method of increasing the cannabinoid levels in a genetically modified Cannabis sativa plant includes genetically modifying the plant to induce the overexpression of the gene that controls the expression of tetrahydrocannabinolic acid (...  
WO/2019/158505A1
A method of extracting at least one cannabinoid from a biomass comprises the following steps: (i) contacting the biomass with a solvent formulation which comprises a C1-4 fluorinated hydrocarbon or a C1-4 hydrofluorocarbon ether, thereby...  
WO/2019/157592A1
A process of producing an edible powder containing cannabis including providing a desired quantity of cannabis oil, a cannabis isolate or a cannabis distillate, mixing the cannabis oil, cannabis isolate or cannabis distillate with a solv...  
WO/2019/158514A1
Disclosed is a process for the oxidation of at least one chroman (C1) in a solvent mixture comprising at least two solvents or in a C-bearing solvent, with a gaseous compound comprising, essentially consisting of, or consisting of oxygen...  
WO/2019/159168A1
The present invention provides cannabinoid derivatives, more specifically cannabidiol (CBD), desoxy-CBD, and desoxy-A9- tetrahydrocannabinol (desoxy-THC) derivatives, which are useful for neuroprotection, treating pain, or treating a dis...  
WO/2018/140738A8
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, which are activators of nuclear factor erythroid 2 (NF-E2) -related factor 2 (Nrf2) and are useful to treat diseases caused by oxidative stress, such as n...  
WO/2019/153088A1
A composition for oral administration comprising a cannabinoid in combination with a stilbenoid or derivative thereof and a solubility enhancing agent is described. Oral dosage forms, in the form of dissolvable tablet or capsule with enh...  
WO/2019/149091A1
The present invention relates to the field of compounds, and in particular to a probucol derivative, a preparation method therefor and use thereof, the probucol derivative having a structure represented by general formula I. The probucol...  
WO/2019/144221A1
Compositions for treating bedsores and methods for treating bedsores are provided. The compositions include a therapeutically effective amount of nabilone and may be formulated for oral or topical administration. The composition may furt...  
WO/2019/145552A1
The present specification discloses methods of purifying one or more cannabinoids from a plant material using unique biphasic solvent systems and liquid-liquid chromatography as centrifugation partitioning chromatography (CPC) or counter...  
WO/2019/141229A1
The present invention involves compounds as PPAR agonists and applications thereof. The compounds involved are novel peroxisome proliferator-activated receptor (PPAR) γ receptor agonists and can inhibit the production of mitochondrial r...  
WO/2019/129909A1
The present invention describes compounds of formula I comprising a central prenylated benzopyran structure. Said compounds of formula I, stereoisomers and pharmaceutically acceptable salts thereof exhibit activity as PPARα, PPARγ agon...  
WO/2019/128175A1
Disclosed are a cocrystal of tocopherol and proline and a preparation method therefor. The cocrystal is in crystalline or partially crystalline form in the environment of normal pressure and room temperature. Compared to the existing toc...  
WO/2019/126872A1
The disclosure relates to solid formulations comprising decarboxylated cannabis resin. The disclosure provides rapidly disintegrating sublingual tablet formulations comprising decarboxylated cannabis resin, and methods for making and usi...  

Matches 301 - 350 out of 15,224